Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporin A 0.1% Emulsion for Keratoconjunctivitis Sicca
NCT00001731Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Nov 1997
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in keratoconjunctivitis sicca (KCS) comparing Cyclosporin A 0.1% with Vehicle Control (2 arms). Started Nov 1997; status: completed.
02
Drugs
cyclosporine
03
Conditions
keratoconjunctivitis sicca (KCS)
Beyond the preview
Go deeper on NCT00001731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001731.